STOCK TITAN

The Joint Corp. Announces $5 Million Stock Repurchase Program

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
buybacks
The Joint Corp (NASDAQ: JYNT), the largest U.S. chiropractic care provider through The Joint Chiropractic network, has announced a $5 million stock repurchase program starting August 2025. CEO Sanjiv Razdan stated the buyback reflects board confidence in their long-term strategy, refranchising program, and projected cash flow generation. The program, which runs until June 3, 2027, allows for repurchases through open market or private transactions, with timing and amounts determined by the board's finance committee. Management believes the company's franchise model and long-term value are currently undervalued in the stock price.
The Joint Corp (NASDAQ: JYNT), il principale fornitore di cure chiropratiche negli Stati Uniti attraverso la rete The Joint Chiropractic, ha annunciato un programma di riacquisto azionario da 5 milioni di dollari a partire da agosto 2025. Il CEO Sanjiv Razdan ha dichiarato che il riacquisto riflette la fiducia del consiglio nella strategia a lungo termine, nel programma di rifranchising e nella generazione prevista di flussi di cassa. Il programma, che durerà fino al 3 giugno 2027, consente riacquisti sia tramite mercato aperto che transazioni private, con tempi e quantità decisi dal comitato finanziario del consiglio. La direzione ritiene che il modello di franchising dell'azienda e il valore a lungo termine siano attualmente sottovalutati nel prezzo delle azioni.
The Joint Corp (NASDAQ: JYNT), el mayor proveedor de atención quiropráctica en EE.UU. a través de la red The Joint Chiropractic, ha anunciado un programa de recompra de acciones por 5 millones de dólares que comenzará en agosto de 2025. El CEO Sanjiv Razdan afirmó que la recompra refleja la confianza del consejo en su estrategia a largo plazo, el programa de refranquiciamiento y la generación proyectada de flujo de caja. El programa, que se extiende hasta el 3 de junio de 2027, permite recompras mediante mercado abierto o transacciones privadas, con tiempos y cantidades determinados por el comité financiero del consejo. La dirección considera que el modelo de franquicias y el valor a largo plazo de la empresa están actualmente subvalorados en el precio de las acciones.
The Joint Corp (NASDAQ: JYNT)는 The Joint Chiropractic 네트워크를 통해 미국 최대의 카이로프랙틱 케어 제공업체로, 2025년 8월부터 500만 달러 규모의 자사주 매입 프로그램을 발표했습니다. CEO Sanjiv Razdan는 이번 자사주 매입이 이사회의 장기 전략, 리프랜차이징 프로그램 및 예상 현금 흐름 창출에 대한 신뢰를 반영한다고 밝혔습니다. 이 프로그램은 2027년 6월 3일까지 진행되며, 공개 시장 또는 비공개 거래를 통해 매입이 가능하며 시기와 금액은 이사회 재무위원회가 결정합니다. 경영진은 회사의 프랜차이즈 모델과 장기 가치가 현재 주가에 저평가되어 있다고 보고 있습니다.
The Joint Corp (NASDAQ : JYNT), principal fournisseur américain de soins chiropratiques via le réseau The Joint Chiropractic, a annoncé un programme de rachat d'actions de 5 millions de dollars à partir d'août 2025. Le PDG Sanjiv Razdan a déclaré que ce rachat reflète la confiance du conseil d'administration dans leur stratégie à long terme, leur programme de refranchisage et la génération prévue de flux de trésorerie. Ce programme, qui se poursuivra jusqu'au 3 juin 2027, permet des rachats via le marché ouvert ou des transactions privées, le calendrier et les montants étant déterminés par le comité financier du conseil. La direction estime que le modèle de franchise de l'entreprise et sa valeur à long terme sont actuellement sous-évalués dans le cours de l'action.
The Joint Corp (NASDAQ: JYNT), der größte US-amerikanische Anbieter von Chiropraktik-Dienstleistungen über das Netzwerk The Joint Chiropractic, hat ein Aktienrückkaufprogramm in Höhe von 5 Millionen US-Dollar ab August 2025 angekündigt. CEO Sanjiv Razdan erklärte, dass der Rückkauf das Vertrauen des Vorstands in die langfristige Strategie, das Refranchising-Programm und die prognostizierte Cashflow-Generierung widerspiegelt. Das Programm läuft bis zum 3. Juni 2027 und erlaubt Rückkäufe über den offenen Markt oder private Transaktionen, wobei Zeitpunkt und Menge vom Finanzausschuss des Vorstands festgelegt werden. Das Management ist der Ansicht, dass das Franchise-Modell des Unternehmens und dessen langfristiger Wert im Aktienkurs derzeit unterbewertet sind.
Positive
  • Board authorizes $5 million stock buyback program indicating confidence in company's future
  • Management believes current stock price undervalues company's franchise model and long-term potential
  • Program demonstrates commitment to returning value to shareholders
  • Company projects strong cash flow generation to support buyback
Negative
  • Relatively small buyback amount of $5 million may limit impact on share price
  • No guarantee on the number of shares to be repurchased as program is discretionary

SCOTTSDALE, Ariz., June 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that its board of directors has authorized a stock repurchase program expected to begin in August 2025 under which the company may repurchase up to $5 million of its outstanding common stock.

“The stock buyback reflects the board’s confidence in our long-term strategy, refranchising program and our projected cash flow generation,” said Sanjiv Razdan, chief executive officer, president and director of The Joint Corp. “We believe our franchise model and long-term valuation are not yet fully recognized in our current stock price. This stock repurchase program underscores our commitment to disciplined capital allocation and delivering value to our stockholders.”

Repurchases may be made from time to time in open market transactions, privately negotiated transactions, or by other means, in accordance with applicable securities laws and subject to market conditions and other factors. The timing, number and amount of any repurchases will be determined by the company’s finance committee of the board of directors at its discretion. The stock repurchase program does not obligate the company to acquire any particular amount of common stock, has a termination date of June 3, 2027 and may be suspended or discontinued at any time.

About The Joint Corp. (NASDAQ: JYNT)

The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. Headquartered in Scottsdale, with over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times’ annual “Top 400” and “Fast & Serious” list of 40 smartest growing brands. Entrepreneur named The Joint “No. 1 in Chiropractic Services,” and is regularly ranked on the publication’s “Franchise 500,” the “Fastest-Growing Franchises,” the “Best of the Best” lists, as well as its “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners.” SUCCESS named the company as one of the “Top 50 Franchises” in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. To learn about franchise opportunities, visit www.thejointfranchise.com.

Business Structure

The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.

Forward-Looking Statements

This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Words such as, "anticipates," "believes," "continues," "estimates," "expects," "goal," "objectives," "intends," "may," "opportunity," "plans," "potential," "near-term," "long-term," "projections," "assumptions," "projects," "guidance," "forecasts," "outlook," "target," "trends," "should," "could," "would," "will," and similar expressions are intended to identify such forward-looking statements. Specific forward-looking statements made in this press release include, among others, our belief that the stock buyback reflects the board’s confidence in our long-term strategy, refranchising program and our projected cash flow generation; that our franchise model and long-term valuation are not yet fully recognized in our current stock price, and that the stock repurchase program underscores our commitment to disciplined capital allocation and delivering value to our stockholders. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, which has increased our costs and which could otherwise negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and other factors described in our filings with the SEC, including in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 14, 2025 and subsequently filed current and quarterly reports. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.

Media Contact:
Margie Wojciechowski, The Joint Corp., margie.wojciechowski@thejoint.com

Investor Contact:
Kirsten Chapman, Alliance Advisors IR, 415-433-3777, thejointinvestor@allianceadvisors.com


FAQ

What is the size of JYNT's stock buyback program announced in June 2025?

The Joint Corp announced a $5 million stock repurchase program of its outstanding common stock.

When does The Joint Corp's 2025 stock buyback program start and end?

The buyback program is expected to begin in August 2025 and has a termination date of June 3, 2027.

Why did The Joint Corp announce a stock repurchase program?

The company believes its franchise model and long-term value are undervalued at current stock price levels and wants to demonstrate commitment to delivering shareholder value.

How will JYNT implement its stock repurchase program?

Repurchases may be made through open market transactions, privately negotiated transactions, or other means, with timing and amounts determined by the board's finance committee.

Can The Joint Corp terminate its buyback program early?

Yes, the stock repurchase program may be suspended or discontinued at any time, as it does not obligate the company to acquire any particular amount of common stock.
Joint Corp

NASDAQ:JYNT

JYNT Rankings

JYNT Latest News

JYNT Stock Data

154.25M
14.84M
2.21%
74.82%
2.71%
Medical Care Facilities
Patent Owners & Lessors
Link
United States
SCOTTSDALE